Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DAWNZERA (AUTOINJECTOR) | Ionis Pharmaceuticals | N-219407 RX | 2025-08-21 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
dawnzera | New Drug Application | 2025-09-24 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hereditary angioedemas | D054179 | EFO_0004131 | — | — | 2 | 2 | — | 1 | 5 |
Angioedema | D000799 | EFO_0005532 | T78.3 | — | 2 | 2 | — | 1 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Drug common name | Donidalorsen |
INN | donidalorsen |
Description | Donidalorsen is an oligonucleotide pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Oligonucleotide |
Drug class | antisense oligonucleotides |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4650235 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | ZD4D8M32TL (ChemIDplus, GSRS) |